13F-HR filed by Seven Fleet Capital Management LP
Seven Fleet Capital Management LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-17, with 96 holding rows worth $605,916,390.
- Accession
- 0001013594-26-000921
- Filer
- CIK 2092021
- Filed
- 2026-08-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 114 entries on the cover page, a total value of $605,916,390 stated on the cover page (in dollars after the unit check, H1), rows summing to $605,916,390 with VALUE read as dollars as filed, 13F file number 028-26709. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerDV Trading LLC028-26555
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,886,236 | $134,017,068 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 3,228,144 | $95,660,985 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 242,029 | $45,327,191 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 774,501 | $26,782,245 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 256,603 | $20,458,957 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 365,386 | $18,543,340 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 111,334 | $14,836,369 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 770,765 | $14,243,737 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 110,393 | $12,923,709 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 433,147 | $11,902,879 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 4,347,826 | $10,652,174 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 118,240 | $10,072,866 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,504,400 | $9,940,323 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 80,000 | $9,835,200 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 246,606 | $8,567,092 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 117,067 | $7,909,873 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 368,305 | $7,828,524 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 220,126 | $7,790,259 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 284,430 | $7,398,024 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 28,826 | $7,055,740 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 148,647 | $6,992,355 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 64,723 | $6,309,198 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 147,510 | $5,708,637 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 308,007 | $5,642,689 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 45,400 | $5,565,132 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,001,373 | $5,557,620 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,330,500 | $4,310,820 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,085,398 | $4,070,243 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 610,785 | $4,037,289 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 159,118 | $3,794,182 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 178,222 | $3,334,534 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 86,664 | $3,224,767 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 11,869 | $3,165,700 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 403,545 | $3,119,403 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 136,016 | $2,924,756 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 736,077 | $2,870,700 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 4,973 | $2,670,252 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 7,540 | $2,524,317 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 348,265 | $2,409,994 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 56,900 | $2,111,559 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 33,300 | $2,084,468 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 309,103 | $1,904,074 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 381,169 | $1,780,059 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 29,800 | $1,777,570 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 16,252 | $1,700,284 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 77,930 | $1,645,046 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 317,600 | $1,451,432 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 26,800 | $1,441,572 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 154,153 | $1,416,666 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 37,865 | $1,411,229 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,057,228 | $1,353,252 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 113,207 | $1,301,881 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 82,890 | $1,238,377 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 23,285 | $1,220,018 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 13,300 | $1,180,774 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 332,613 | $1,134,210 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 240,963 | $1,098,791 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 73,300 | $1,090,930 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 208,946 | $1,011,299 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 60,541 | $992,267 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 45,598 | $833,430 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 230,406 | $771,860 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 200,141 | $756,533 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 411,065 | $711,142 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 230,921 | $704,309 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 346,900 | $704,207 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 22,060 | $693,787 | dollars as filed | |
| iShares U.S. Medical Devices ETF | 464288810 | SHS | 13,800 | $681,858 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 60,107 | $659,975 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 1,774 | $659,343 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 143,137 | $588,293 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 272,204 | $568,906 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 78,057 | $541,716 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 103,400 | $521,136 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 233,066 | $510,415 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 51,024 | $510,240 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 6,395 | $448,929 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 43,300 | $423,907 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 16,800 | $406,560 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 31,476 | $393,765 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 270,233 | $362,112 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 191,354 | $338,697 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 10,702 | $337,755 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 6,000 | $331,200 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 8,804 | $302,153 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 1,400 | $265,468 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 14,540 | $261,138 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 7,745 | $255,353 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 7,404 | $251,884 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 78,842 | $201,836 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 21,432 | $201,032 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 10,600 | $139,496 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 19,048 | $99,812 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 53,569 | $71,782 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 18,089 | $66,206 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 338 | $15,254 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-26-000921 | this filing | 2026-08-17 | acceptance time not in the bulk data set |